INOVA HEALTH SYSTEM and the University of Virginia agreed to form a research and education partnership to collaborate on research, medical education, and the recruitment of researchers, scientists and investigators.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
